Biotech & Pharma

STAT+: Trump's drive to get Europe to pay more for drugs creates uncertainty for countries, patients

26 sec read5 views0 listens

President Trump's push for Europe to pay more for drugs to reduce U.S. costs has introduced uncertainty across European countries regarding drug pricing and access. This move threatens potential price hikes and restricted drug availability in Europe, impacting patient access and healthcare systems. Content creators should highlight the complex implications of global drug pricing policies on healthcare accessibility and affordability.

Read the full article at STAT Pharma

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

You Might Like

Biotech & Pharma13 hours ago23 sec read

Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer

Aprea Therapeutics is accelerating enrollment in its Phase I trial of APR-1051, a WEE1 kinase inhibitor, after observing early signs of clinical activity. This expansion aims to gather more data on the drug's efficacy and safety, particularly for pat...

Ali Nemati

Biotech & Pharma13 hours ago29 sec read

The Next Wave of ADC Innovation: The Science Behind Dual-Payload Bioconjugates

Cindy Cheng, PhD, will discuss the development of dual-payload antibody-drug conjugates (dp-ADCs) to enhance efficacy and overcome drug resistance in cancer treatments. This innovation is crucial for biotech and pharma developers aiming to improve th...

Ali Nemati

Legal & Policy1 day ago32 sec read

A Tribute, A Tactic, Or An Appellate Issue?

A prosecutor's use of hair bows in the Lindsay Clancy murder trial is being scrutinized as a potential tactic that could lead to an appeal, rather than relying solely on evidence. Separately, private equity firm Charlesbank Capital Partners is report...

Ali Nemati